Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter

Core value dossiers for medical technologies

Essential tool to support market access and marketing efforts through the lifecycle of the product

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Recent news and posts

Tags

Use tags to find relevant records
3D printed implants
Ablation methods
Allogeneic mesenchymal stem cells
Ambulatory ECG monitoring
Aortic abdominal aneurysm
Aortic root replacement
Arthroplasty
Arthroscopy
Assisted ventilation
Atherectomy
Austria
Autologous chondrocyte implantation
Automated external defibrillator
AV fistula
AV graft
Balloon kyphoplasty
Bariatric surgery
Baroreflex activation therapy
Barrett’s oesophagus
Belgium
Benign prostatic hyperplasia
Biopsy
Bone Conductive Hearing Device
Breast reconstruction
Bronchial thermoplasty
Burns
Caesarean section
Cancer
Capsule endoscopy
Carbon ion therapy
Cardiac ablation
Cardiac computer tomography
Cardiac pacemaker
Cardiac resynchronization therapy
Cardiac Resynchronization Therapy Defibrillator (CRT-D)
Cardiovascular devices
Cardiovascular procedures
Carotid endarterectomy
Cataract
Cell therapy
Cholecystectomy
Chronic obstructive pulmonary disease
Chronic wounds
Clinical guidelines
Cochlear implants
Commissioning
Companion diagnostic tests
Computed tomography
Conditional reimbursement
Connected medical devices
Continuous glucose monitoring (CGM)
Coronary interventions
Coronary percutaneous revascularization procedures
Coronary procedures
Coronavirus
Coverage with evidence development (CED)
See all tags

Join MTRC at Pharma 4.0 - Digital Healthcare Conference in Berlin, 22–23 May 2025

MTRC is pleased to participate in the Pharma 4.0 - Digital Healthcare Conference, taking place 22–23 May 2025 in Berlin, Germany.

Our Senior Reimbursement Consultant, Julia Mazur, will represent MTRC at the event and will be available at Booth #9 to discuss your company’s needs in European Market Access, Health Economics, and Evidence Synthesis services for complex MedTech challenges.

As part of the conference programme, Julia Mazur will deliver a presentation titled “Reimbursement of Digital Technologies in Europe” on 22 May at 10:50 AM. The session will provide valuable insights into the evolving role of digitalization in market access and health economics.

If you would like to schedule a meeting in advance, feel free to contact us at info@mtrconsult.com.

We look forward to connecting with you in Berlin!

Tags
Services of MTRC

The latest related news

26
May 2025

MTRC has released a White Paper "Evidence requirements for the creation of IVD reimbursement (NABM) codes in France"

MTRC is pleased to announce the release of its latest White Paper: "Evidence requirements for the creation of IVD reimbursement (NABM) codes in France". This document sheds light on the broader evidence requirements and decision-making framework used by HAS, offering diagnostics manufacturers critical insights into the expectations and potential challenges of securing NABM reimbursement.
Read more
20
May 2025

Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to understand the potential scope of our support better. From the week of the 19th of May, we plan to work on 17 projects. Review the complete list of planned activities in this post.
Read more